Smartleaf Asset Management LLC Dyne Therapeutics, Inc. Transaction History
Smartleaf Asset Management LLC
- $1.13 Trillion
- Q2 2025
A detailed history of Smartleaf Asset Management LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 9 shares of DYN stock, worth $113. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9Holding current value
$113% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding DYN
# of Institutions
211Shares Held
122MCall Options Held
36.5KPut Options Held
74.3K-
Ra Capital Management, L.P. Boston, MA9.71MShares$123 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$119 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$116 Million19.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.65MShares$96.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$93.4 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $655M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...